Chief Scientist meets with PASYKAF

The Chief Scientist for Research, Innovation, and Technology, Demetris Skourides, held a meeting with senior representatives of the Cyprus Association of Cancer Patients and Friends (PASYKAF) to discuss how technology and Artificial Intelligence can support the organisation’s mission in addressing cancer and advancing its important work across Cyprus.

According to the Cyprus Cancer Registry, cancer is the second leading cause of death in Cyprus, accounting for 24% of total annual deaths. Of particular concern is the growing incidence of colorectal cancer among younger adults.

Representing PASYKAF at the meeting were Nicolas Philippou, Chief Executive Officer, Christos Tryfonos, Chief Support Operations Officer and Director of Services and Dr Panayiotis Andreou, Chief Data Officer Dr Andreou has taken on this role on a voluntary basis as part of the ongoing collaboration between UCLan Cyprus and PASYKAF.

Discussions focused on UCLan Cyprus’ voluntary contribution to PASYKAF’s data strategy, and the progress made thus far, which includes the analysis of strategic requirements and the design of a central data warehouse. The meeting also included a presentation of future plans to integrate emerging technologies, including Artificial Intelligence, to personalize care services, anticipate patient needs, and optimize the organisation’s operations.

The potential development of Digital Twins was also discussed, as a means to simulate complex scenarios and better understand disease progression and treatment outcomes. This innovation is expected to enable more targeted, cost-effective interventions and enhanced, personalised support for patients and their families.

“This is a powerful example of how private research organisations - and especially universities - can offer meaningful, voluntary contributions to society by translating research knowledge into community impact,” noted Skourides.

He also emphasised that, “by effectively utilising the data collected through PASYKAF’s programmes and patient support services, along with new data generated through research partnerships, as well as by harnessing the power of advanced technologies and AI, PASYKAF can sustainably scale its impact and develop innovative care and customised patient support solutions for cancer patients and their families.”

The Chief Scientist expressed his deep respect for the people of PASYKAF and affirmed his belief that when science and technology align with a shared vision, they can drive meaningful and lasting change. “I will continue to stand alongside PASYKAF and actively support initiatives that bridge innovation with social impact - because progress truly matters when it touches and improves human lives,” he concluded.